These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 9346769)

  • 1. Loss of serum HBsAg after interferon-A therapy in liver transplant patients with recurrent hepatitis-B infection.
    Ben-Ari Z; Shmueli D; Shapira Z; Mor E; Tur-Kaspa R
    Liver Transpl Surg; 1997 Jul; 3(4):394-7. PubMed ID: 9346769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recurrence-free long-term survival after liver transplantation for hepatitis B using interferon-alpha pretransplant and hepatitis B immune globulin posttransplant.
    Tchervenkov JI; Tector AJ; Barkun JS; Sherker A; Forbes CD; Elias N; Cantarovich M; Cleland P; Metrakos P; Meakins JL
    Ann Surg; 1997 Sep; 226(3):356-65; discussion 365-8. PubMed ID: 9339942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interferon alfa for recurrent hepatitis B infection after liver transplantation.
    Terrault NA; Holland CC; Ferrell L; Hahn JA; Lake JR; Roberts JP; Ascher NL; Wright TL
    Liver Transpl Surg; 1996 Mar; 2(2):132-8. PubMed ID: 9346639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. De novo and apparent de novo hepatitis B virus infection after liver transplantation.
    Roche B; Samuel D; Gigou M; Feray C; Virot V; Schmets L; David MF; Arulnaden JL; Bismuth A; Reynes M; Bismuth H
    J Hepatol; 1997 Mar; 26(3):517-26. PubMed ID: 9075658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retransplantation of patients with severe posttransplant hepatitis B in the first allograft.
    Ishitani M; McGory R; Dickson R; Caldwell S; Bickston S; McCullough C; Pruett T; Terrault N; Roberts J; Ascher N; Wright T; Lake J
    Transplantation; 1997 Aug; 64(3):410-4. PubMed ID: 9275104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized, controlled trial of a 24-month course of interferon alfa 2b in patients with chronic hepatitis B who had hepatitis B virus DNA without hepatitis B e antigen in serum.
    Lampertico P; Del Ninno E; Manzin A; Donato MF; Rumi MG; Lunghi G; Morabito A; Clementi M; Colombo M
    Hepatology; 1997 Dec; 26(6):1621-5. PubMed ID: 9398007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term follow-up of hepatitis B virus-infected recipients after orthotopic liver transplantation.
    König V; Hopf U; Neuhaus P; Bauditz J; Schmidt CA; Blumhardt G; Bechstein WO; Neuhaus R; Lobeck H
    Transplantation; 1994 Sep; 58(5):553-9. PubMed ID: 8091481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interferon-alpha 2b improves short-term survival in patients transplanted for chronic liver failure caused by hepatitis B.
    Hassanein T; Colantoni A; De Maria N; Van Thiel DH
    J Viral Hepat; 1996 Nov; 3(6):333-40. PubMed ID: 8947886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostaglandin E in the treatment of recurrent hepatitis B infection after orthotopic liver transplantation.
    Flowers M; Sherker A; Sinclair SB; Greig PD; Cameron R; Phillips MJ; Blendis L; Chung SW; Levy GA
    Transplantation; 1994 Jul; 58(2):183-92. PubMed ID: 8042236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized, controlled trial of recombinant alpha-interferon therapy for chronic hepatitis B.
    Di Bisceglie AM; Fong TL; Fried MW; Swain MG; Baker B; Korenman J; Bergasa NV; Waggoner JG; Park Y; Hoofnagle JH
    Am J Gastroenterol; 1993 Nov; 88(11):1887-92. PubMed ID: 8237937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-dose recombinant interferon therapy in anti-HBe-positive chronic hepatitis B in Asian Indians.
    Guptan RC; Thakur V; Malhotra V; Sarin SK
    J Gastroenterol Hepatol; 1998 Jul; 13(7):675-9. PubMed ID: 9715416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impaired response to alpha interferon in patients with an inapparent hepatitis B and hepatitis C virus coinfection.
    Zignego AL; Fontana R; Puliti S; Barbagli S; Monti M; Careccia G; Giannelli F; Giannini C; Buzzelli G; Brunetto MR; Bonino F; Gentilini P
    Arch Virol; 1997; 142(3):535-44. PubMed ID: 9349299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term remission of chronic hepatitis B after alpha-interferon therapy.
    Korenman J; Baker B; Waggoner J; Everhart JE; Di Bisceglie AM; Hoofnagle JH
    Ann Intern Med; 1991 Apr; 114(8):629-34. PubMed ID: 2003708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interferon alfa-2b therapy in children with chronic hepatitis B.
    Sokal EM; Wirth S; Goyens P; Depreterre A; Cornu C
    Gut; 1993; 34(2 Suppl):S87-90. PubMed ID: 8314496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lamivudine prophylaxis of liver allograft HBV reinfection in HBV related cirrhotic patients after liver transplantation.
    Lu SC; Yan LN; Li B; Wen TF; Zhao JC; Cheng NS; Liu C; Liu J; Wang XB; Li XD; Qin S; Zhao LS; Lei BJ; Zhang XH
    Hepatobiliary Pancreat Dis Int; 2004 Feb; 3(1):26-32. PubMed ID: 14969833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relevance of inapparent coinfection by hepatitis B virus in alpha interferon-treated patients with hepatitis C virus chronic hepatitis.
    Zignego AL; Fontana R; Puliti S; Barbagli S; Monti M; Careccia G; Giannelli F; Giannini C; Buzzelli G; Brunetto MR; Bonino F; Gentilini P
    J Med Virol; 1997 Apr; 51(4):313-8. PubMed ID: 9093946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pretransplantation interferon treatment and recurrence of hepatitis B virus infection after liver transplantation for hepatitis B-related end-stage liver disease.
    Marcellin P; Samuel D; Areias J; Loriot MA; Arulnaden JL; Gigou M; David MF; Bismuth A; Reynes M; Bréchot C
    Hepatology; 1994 Jan; 19(1):6-12. PubMed ID: 8276368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of granulocyte-macrophage colony-stimulating factor or lamivudine combination with recombinant interferon in non-responders to interferon in hepatitis B virus-related chronic liver disease patients.
    Guptan RC; Thakur V; Kazim SN; Sarin SK
    J Gastroenterol Hepatol; 2002 Jul; 17(7):765-71. PubMed ID: 12121506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complete hepatitis B virus prophylaxis withdrawal in hepatitis B surface antigen-positive liver transplant recipients after longterm minimal immunosuppression.
    Lenci I; Baiocchi L; Tariciotti L; Di Paolo D; Milana M; Santopaolo F; Manzia TM; Toti L; Svicher V; Tisone G; Perno CF; Angelico M
    Liver Transpl; 2016 Sep; 22(9):1205-13. PubMed ID: 27272189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preoperative serum levels of wild-type and hepatitis B e antigen-negative hepatitis B virus (HBV) and graft infection after liver transplantation for HBV-related hepatocellular carcinoma.
    Mazzaferro V; Brunetto MR; Pasquali M; Regalia E; Pulvirenti A; Baratti D; Makowka L; Van Thiel D; Bonino F
    J Viral Hepat; 1997 Jul; 4(4):235-42. PubMed ID: 9278221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.